Companies: 10,795·Total market cap: $144.5T
Novartis AG

Novartis AG

NVSNYSEHealthcare● Active
$149.16
+$0.76(+0.51%)
Market Cap$284.6B
P/E Ratio
52W High$170.46
52W Low$112.34
Overview

Novartis AG (NVS) · Balance Sheet

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · NVS · as of 2026-06-08

Financial statements

Total Assets · Total Liabilities · Equity
Breakdown2025-122024-122023-122022-122021-12
Assets
Cash & ST Investments$11.59B$13.35B$13.96B$18.61B$28.11B
Net Receivables$10.93B$8.21B$9.38B$9.89B$9.62B
Inventory$6.27B$5.72B$5.91B$7.17B$6.67B
Total Current Assets$30.46B$29.70B$30.48B$36.91B$45.72B
PP&E Net$12.35B$10.87B$10.92B$12.20B$13.11B
Goodwill$25.57B$24.76B$23.34B$29.30B$29.59B
Intangible Assets$29.41B$26.91B$26.88B$31.64B$34.18B
Total Assets$115.57B$102.25B$99.94B$117.45B$131.79B
Liabilities
Short-Term Debt$5.78B$8.09B$6.08B$5.88B$6.23B
Accounts Payable$4.46B$4.57B$4.93B$5.15B$5.55B
Total Current Liabilities$27.28B$28.69B$26.39B$28.66B$30.21B
Long-Term Debt$29.59B$21.37B$18.44B$20.24B$22.90B
Total Liabilities$69.02B$58.12B$53.20B$58.03B$63.97B
Stockholders Equity
Retained Earnings$44.72B$46.56B$49.65B$63.54B$70.99B
Total Stockholders Equity$46.13B$44.05B$46.67B$59.34B$67.66B
Total Liab & Equity(computed)$115.15B$102.17B$99.86B$117.37B$131.63B
Debt Summary
Total Debt$37.03B$31.26B$26.35B$27.91B$31.02B
Net Debt$25.60B$19.80B$12.96B$20.39B$18.62B

Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B

Explore more Novartis AG data

About Novartis AG (NVS) Balance Sheet

Novartis AG (NVS) balance sheet shows total assets of $115.57B with cash of $11.59B. Total liabilities are $69.02B, total debt $37.03B, and stockholders equity $46.13B.

Frequently asked questions

NVS · 4 questions

Novartis AG has total debt of $37.03B with net debt of $25.60B.

NVS total debtnet debtdebt to equity

· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08